SYRS
PINK Syros Pharmaceuticals, Inc.$0.0004 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0004, and at the day’s high of $0.0004
- YTD change
- +14.29%
- vs 20-day SMA
- -59.18%
- vs 200-day SMA
- +17.90%
Price ranges
Price & Performance
+0.00 (+0.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $243.7500
- SYRS is up 14% since the beginning of the year
- SYRS is down 92% over the past 12 months
- SYRS is up 0% over the past 1 month
- 0% of all SYRS investors are betting against SYRS
SYRS reads n/a: price sits above one of the two key moving averages, the 12-month move is -92.0%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +0.00%
- vs 8-day SMA
- +0.00%
No alerts for SYRS in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.